RAD-150 (TLB-150), (10mg/capsule) 60 Capsules

RAD-150 (TLB-150) is a benzoate ester derivative of RAD-140 (Testolone) designed as a prodrug that undergoes ester hydrolysis to release RAD-140 as the active androgen receptor (AR) agonist. The addition of the benzoate ester modifies the physicochemical properties of the parent molecule, making RAD-150 a useful research tool for investigating prodrug design strategies, esterification chemistry, and metabolic conversion mechanisms. Experimental studies have examined its interactions with AR-mediated signaling pathways, ligand-receptor binding dynamics, and receptor-associated transcriptional regulation following conversion to the active species. Research applications include prodrug pharmacology, ester hydrolysis studies, androgen receptor signaling investigation, structure-activity relationship analysis, and mechanistic evaluation of esterified androgen receptor modulators.